Lineage Cell Therapeutics logo

Lineage Cell Therapeutics

LCTX | AMEX
Chart Builder DCF Calculator
$0.80
-$0.11 (-12.53%)
At close: Nov 16, 2026, 4:00 PM ET
$0.86
+$0.06 (+7.50%)
After-hours: Nov 16, 2026, 7:48 PM ET
-12.53%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
66
Fundamentals Strong
Market Sentiment Neutral
Moat Narrow
Sector Rank #83/1021 (Top 8%)

Key Statistics

Market Data

Market Cap $201.12M
1D Range
0.77 0.95
52W Range
0.77 1.96

Valuation (TTM)

PE 33.47
PB 3.05
EV/EBITDA -73.27

Valuation (NTM)

Forward PE N/A
Forward PEG -1.71
Price Target $4.00
Loading financial charts...

Profile

Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, developing cell replacement therapies to treat serious medical conditions in the United States and internationally. The company...

Sector Healthcare
Industry Biotechnology
Employees 75
IPO Date Mar 5, 1992
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Latest Earnings
Nov 12, 2026
EPS
-$0.03
Miss -5.01%
REV
$1.43M
Miss -38.14%
Next Earnings
Mar 4, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
3
Consensus
Buy
Price Target
$4.00
Upside
+400.00%
Buy (3)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.